Abstract
The value of clinical use of tumor markers CEA and CA15-3 for early detection of recurrent breast cancer still is a controversial. This study was investigated relationship between tumor markers CEA and CA15-3 and recurrence breast cancer. Data regarding 147 women who had breast cancer were entered into the study. Patients were reviewed for 120 months after treatment. Maximum time for relapse was considered a 6 months. Results were showed recurrence cancer in 20% of diagnosed patients. All of them in diagnosis time had a higher of normal tumor markers (CA<3, CA15-3<30).These observations indicated that CA15-3 is a sensitive tumor marker for diagnosis especially for recurrent breast cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
